Veru Inc.

05/11/2022 | Press release | Distributed by Public on 05/11/2022 04:42

FDA States that Veru Should Submit Request for Emergency Use Authorization (EUA) Based on Positive Efficacy and Safety Data from the Phase 3 Clinical Study of Sabizabulin in[...]